A GLP nonclinical study is an in vivo or in vitro experiment used to determine which of the following?

A GLP nonclinical study is an in vivo or in vitro experiment used to determine which of the following?

• A. Safety of the test article
• B. Pharmacokinetics in humans
• C. Market competition
• D. Environmental impact

Answer: (A)

GLP nonclinical studies are conducted to determine the safety of the test article before it reaches humans. These studies, whether in living animals or in cells and tissues, are designed to identify potential toxic effects, target organs, and dose levels that cause harm. The Good Laboratory Practice framework ensures that the methods, data collection, and documentation are standardized and reliable, so regulators can assess risks accurately. While pharmacokinetics in humans is evaluated later in clinical trials (and nonclinical PK can be explored, its primary purpose in this context is safety evaluation), environmental impact and market competition are not the focus of these GLP safety studies. So the essential purpose of a GLP nonclinical study is to characterize safety.

GLP nonclinical studies are conducted to determine the safety of the test article before it reaches humans. These studies, whether in living animals or in cells and tissues, are designed to identify potential toxic effects, target organs, and dose levels that cause harm. The Good Laboratory Practice framework ensures that the methods, data collection, and documentation are standardized and reliable, so regulators can assess risks accurately. While pharmacokinetics in humans is evaluated later in clinical trials (and nonclinical PK can be explored, its primary purpose in this context is safety evaluation), environmental impact and market competition are not the focus of these GLP safety studies. So the essential purpose of a GLP nonclinical study is to characterize safety.